Angle Share Discussion Threads

[1liam] 20/10/2022 08:24

Prefabricated rampers Amaretto/Purchaseatthetop on the other board trying to get mug punters to buy. Boy they're getting upset and desperate.Jefferies and the American markets selling off, gearing down continues.Buy price 20p if you're prepared to wait a little longer.

[mrkeysersoze] 20/10/2022 08:16

Liquid Biopsy market not standing still.

Parortix versus below??



October 14, 2022 08:00 AM Eastern Daylight Time

PLEASANTON, Calif. & HONG KONG--(BUSINESS WIRE)--DiaCarta, Ltd. (“DiaCarta” or the “Company”), a precision molecular diagnostics company and developer of novel oncology and infectious disease tests, and HH&L Acquisition Co. (NYSE: HHLA.U, HHLA, HHLA WS) (“HH&L”), a publicly traded special purpose acquisition company (“SPAC”), today announced that they entered into a definitive business combination agreement (the “Business Combination Agreement”) that is expected to result in DiaCarta becoming a publicly listed company (the “Transaction” or “Business Combination”). The Transaction is expected to provide DiaCarta with access to the approximately $414 million cash from HH&L’s IPO proceeds held in trust, assuming no redemptions by HH&L’s shareholders and prior to the payment of transaction expenses, and potential additional financing to catalyze DiaCarta’s growth. The Transaction implies a pre-money equity value of $460 million for DiaCarta on a fully diluted basis and is expected to close in the first quarter of 2023. The Transaction positions DiaCarta to capitalize on significant future growth within existing and new markets.

“As a result of the transaction, DiaCarta will be well positioned to capitalize on significant future growth within our existing customer base and expand into compelling adjacent markets. This transaction represents a major milestone for DiaCarta, which will enable us to further invest in our technology and support pipeline growth”
Tweet this

HH&L is led by Kenneth W. Hitchner, Richard Qi Li and a management team with significant experience in identifying and investing in attractive growth opportunities in the global healthcare industry, and Fenglai Fang, Chairman of HOPU Investments, serves as an adviser.

Upon closing of the Transaction, the combined company will be listed on the New York Stock Exchange. The combined company will continue to be based in Pleasanton, California, and led by Aiguo (Adam) Zhang, Founder and Chief Executive Officer of DiaCarta, and other key members of DiaCarta’s management team.

Angle current Mcap $136m...... above deal $460m


Mr K.

[bones698] 20/10/2022 00:49

In fairness the shareprice tells a story and doesn't lie . All thebtampers have to concede things really haven't gone to plan especially over the last decade one way or another .

FDA approval was a big hurdle for sure but with that out the way otherbhurdles remain and I stick to my comments about the American market and just how difficult it will be to get deals done that generate significant income .

The focus is now on sales and getting to break even inna timely manner . We know they have enough cash until h2 2024 but that doesn't mean sales and deals will be done by then or that more cash will be needed sometime next year if the deals don't generate enough cash to offset the heavy losses .

I am surprised to see it drifting and probably into the 30's again but it also speaks the the markets faith in AN to deliver no matter how rise tinted those glasses are the shreprice tells the story not people on a bulletin board. If you haven't realized that your in the wrong game investing .

My concerns started long ago . The focus on the USA market and ignoring the other markets where they had approval was worrying . Putting all your eggs in one basket which is notoriously hard to crack for foreign companies . Couple that with the path taken and dillution meant there eetrba lot more hurdles to navigate and a lot longer timeline .

Only if and when they break even can this be looked at as an investment and I think that is going to take a while yet again if at all. Also don't forget the delay for any deals and sales to hit the bottom line in accounts .

Think this will fall further with the seller around and people have to be worried a cheap move could be made the further it falls. Ii's provide some protection but in the end if they see a profit don't expect them to hold out like pis will want .

[zeus19] 19/10/2022 23:02

Oh wait, your average on EUA is now apparently 13p. So only needs to up 160% to break even LOLZ

[zeus19] 19/10/2022 23:00

If you paid 30p for EUA for your nephew thats now sitting at 5p, you deserve the same hahaha At least AGL have cash until 2024. Cant see EUA surviving past Q2 23 with all those sanctions LOLZ

[halland75] 19/10/2022 22:31

If you paid 160p for this dog, you deserve your losses.
7p is too much!
Hopefully red will continue to flow here.

Me likey. 😊😊😊

[1liam] 19/10/2022 21:44

Smraynot, you only know how to sell for 1p.

[zeus19] 19/10/2022 21:32

Im here for a hug if you need one

[antonagis] 19/10/2022 21:32

ZEUS vainly attempting to rally the troops. As I've stated before this will tumble down significantly while AN runs the show, more like the Muppet Show to be honest. Ignore criminal ramping from AMARETTO and their sidekick PURCHASE. Desperate ramping in an attempt to halt the slide. This will continue to slide and once at 20-30p PURCHASE will say he sold out higher just like he did with ENET and BUSHVELD which were also criminally ramped. Listen to them at your peril IMO.

[zeus19] 19/10/2022 21:29

YAWN. Broken record

[1liiam] 19/10/2022 21:28

You stupid. Lot of cash and no deadline for few year. Stupid

[smraynot] 19/10/2022 21:24

Looking distinctly sad. Let's hope for a 15p takeover.

[zeus19] 19/10/2022 21:09

Yawn. Broken record

[stevelauren23] 19/10/2022 19:30

Why would anyone think a bad deal is better than no deal. Sometimes the best deal is the one you don't do.

Anyone who has ever negotiated anything will know that if the other side agrees to terms too quickly then you could have got more. So I'm really not concerned.

[asdb9] 19/10/2022 19:29

Being facetious old chap

[waterloo01] 19/10/2022 19:24

Fundamentally disagree with that. A bad deal would be just that.

[zeus19] 19/10/2022 18:52

LOLZ. 2 years cash runway and heavily owned by CEO and ii's. Good luck with that 15p target hahahahaha CLOWN

[smraynot] 19/10/2022 18:49

Think a buyout at 15p is the likely scenario I'm afraid. Little hope in the long term otherwise.